Used as an intermediate in pharmaceutical synthesis, particularly in the development of kinase inhibitors and other biologically active compounds. The Boc-protected amine group allows for selective reactivity, making it valuable in multi-step organic syntheses where controlled deprotection and coupling are required. Commonly employed in the preparation of pyridine-based drug candidates, including those targeting cancer and inflammatory diseases. Its bromo substituent enables further functionalization via cross-coupling reactions such as Suzuki or Buchwald-Hartwig aminations, facilitating rapid structural diversification in medicinal chemistry research.